About ImQuest Pharma Therapeutic Focus Product Pipeline Scientific Staff News & Notes Investor Relation Contact Us Careers
  
 
Therapeutic Focus
General Information
Infectious Disease
Cancer
Topical Microbicides
Immune Modulation and
Inflammation
 
News and Notes
April 4th 2008:
ImQuest scientists present important HIV Microbicide results at Microbicides 2008 in Delhi, India.
   
April 1st 2008:
ImQuest publishes results of structure activity relationship study with pyrimidinedione HIV inhibitors.
   
September 24th 2007:
ImQuest Life Sciences announces the appointment of Robert Schooley, M.D. to its Scientific Advisory Board.
   
September 21st 2007:
ImQuest Life Sciences announces the appointment of David Ho, M.D. to its Scientific Advisory Board.
   
September 20th 2007:
ImQuest Life Sciences announces the appointment of Richard J. Whitley, M.D. as Chairman of its Scientific Advisory Board.
   
April 25th 2007:
ImQuest Life Sciences Receives Grant from International Partnership
for Microbicides to Develop Novel Microbicide
   
April 25th 2006:
ImQuest Life Sciences Licenses Piperazine Series of Anti-Cancer Therapeutic
Compounds from Samjin Pharmaceutical Co.
   
 News Archieve
Welcome to ImQuest Life Sciences Welcome to ImQuest Life Sciences
Careers

Please submit current curriculum vitae or resume to the attention of Director, Human Resources, ImQuest Life Sciences Inc., 7340 Executive Way, Suite R, Frederick, Maryland 21704. 
Meet ImQuest Life Sciences's Staff at the Following Scientific Meetings:

International Conference on Antiviral Research (Palm Springs, CA, May 2007)

American Association of Pharmaceutical Science-Biotechnology (San Diego, CA June 2007)

DART-HIV (Cancun, Mexico, December 2006)

Internscience Conference of Antimicrobial Agents and Chemotherapy (Chicago, September 2007)

DART-HCV (Hawaii, December 2007)

 
Copyright © 2006, ImQuest Life Sciences. Site Map | Search | Privacy Policy | Terms & Conditions. Site by Synapse Communications.